| Market Cap | ₹20,525Cr |
| ROE | 8.61% |
| P/E Ratio(TTM) | 65.51 |
| EPS(TTM) | 8.19 |
| P/B Ratio | 5.42 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.29 |
| Book Value | 99.01 |
| Debt to Equity | 0.12 |
| Face Value | 1 |
| Parent Organisation | Cohance Lifesciences |
| Managing Director | Dr V. Prasada Raju |
| Founded | 2018 |
| NSE Symbol | COHANCE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.25 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.30 | ||
| Wockhardt | NA (0.00%) | -427.29 | ||
| Natco Pharma | NA (0.00%) | 10.56 |